Kerry Blanchard
Nessuna posizione attualmente
Profilo
Kerry Levan Blanchard is the founder of Perpetual Medicines Corp.
Currently, he holds director positions at Everest Medicines II Ltd., EverNov Medicines (Zhuhai Hengqin) Co. Ltd., Everstar Medicines Shanghai Ltd., and is an operating partner at CBC Group Co., Ltd.
Previously, he served as the Chief Executive Officer & Executive Director at Everest Medicines Ltd.
from 2020 to 2022, Chief Science Officer at Innovent Biologics, Inc. in 2018-2019, and Senior Vice President at Lilly China Research & Development Co. Ltd.
from 2000 to 2017.
He was also an Associate Professor at Louisiana State University from 1992 to 1999 and a Director at Zymeworks BC, Inc. He received his undergraduate degree in 1977 and his doctorate in 1985 from Indiana University.
Posizioni attive di Kerry Blanchard
| Società | Posizione | Inizio |
|---|---|---|
| CBC Group Co., Ltd. | Corporate Officer/Principal | - |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Direttore/Membro del Consiglio | - |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | Direttore/Membro del Consiglio | - |
| Everstar Medicines Shanghai Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Kerry Blanchard
| Società | Posizione | Fine |
|---|---|---|
| EVEREST MEDICINES LIMITED | Amministratore Delegato | 26/08/2022 |
| INNOVENT BIOLOGICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2019 |
Lilly China Research & Development Co. Ltd.
 Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Corporate Officer/Principal | 01/12/2017 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 10/05/2017 |
| Louisiana State University | Corporate Officer/Principal | 01/01/1999 |
Formazione di Kerry Blanchard
| Indiana University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INNOVENT BIOLOGICS, INC. | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| Aziende private | 6 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| CBC Group Co., Ltd. | |
Everest Medicines II Ltd.
Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Health Technology |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | |
| Everstar Medicines Shanghai Ltd. | |
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Kerry Blanchard
